In collaboration with Geocann, Cronos Group Inc. is happy to announce the release of the first of what is anticipated to be several products that will make use of the cutting-edge VESIsorb® delivery system. Faster absorption and improved bioavailability are provided by this technique. In peer-reviewed published studies, VESIsorb® formulations have established the standard for the industry by providing improved pharmacokinetic performance, including quick absorption, increased plasma concentration, and increased area under the curve.
Mike Gorenstein, Chairman, President, and Chief Executive Officer, Cronos affirmed that “We are committed to bringing breakthrough innovations to the market, providing ...
Read The Full Article On MicroSmallCap.com
Get early insight on hidden secret gems on MicroSmallCap . Follow Crypto, Mining, Cannabis and Energy stocks and get free research reports here .
All content provided by MicroSmallCap is subject to our Terms Of Use and Disclaimer .
For further details see:
Cronos Group and Geocann Work Together to Use VESIsorb® Delivery Technology for Quicker Absorption